1. Home
  2. TEVA vs CNC Comparison

TEVA vs CNC Comparison

Compare TEVA & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • CNC
  • Stock Information
  • Founded
  • TEVA 1901
  • CNC 1984
  • Country
  • TEVA Israel
  • CNC United States
  • Employees
  • TEVA N/A
  • CNC N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • CNC Medical Specialities
  • Sector
  • TEVA Health Care
  • CNC Health Care
  • Exchange
  • TEVA Nasdaq
  • CNC Nasdaq
  • Market Cap
  • TEVA 21.2B
  • CNC 18.5B
  • IPO Year
  • TEVA N/A
  • CNC 2001
  • Fundamental
  • Price
  • TEVA $24.78
  • CNC $38.59
  • Analyst Decision
  • TEVA Strong Buy
  • CNC Hold
  • Analyst Count
  • TEVA 7
  • CNC 17
  • Target Price
  • TEVA $25.86
  • CNC $40.06
  • AVG Volume (30 Days)
  • TEVA 14.1M
  • CNC 10.9M
  • Earning Date
  • TEVA 11-05-2025
  • CNC 10-29-2025
  • Dividend Yield
  • TEVA N/A
  • CNC N/A
  • EPS Growth
  • TEVA N/A
  • CNC N/A
  • EPS
  • TEVA 0.62
  • CNC N/A
  • Revenue
  • TEVA $16,776,000,000.00
  • CNC $167,680,000,000.00
  • Revenue This Year
  • TEVA $4.11
  • CNC $31.16
  • Revenue Next Year
  • TEVA $0.40
  • CNC $0.94
  • P/E Ratio
  • TEVA $39.23
  • CNC N/A
  • Revenue Growth
  • TEVA 0.02
  • CNC 14.57
  • 52 Week Low
  • TEVA $12.47
  • CNC $25.08
  • 52 Week High
  • TEVA $26.38
  • CNC $66.81
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 66.17
  • CNC 59.33
  • Support Level
  • TEVA $24.01
  • CNC $34.39
  • Resistance Level
  • TEVA $26.38
  • CNC $37.13
  • Average True Range (ATR)
  • TEVA 0.91
  • CNC 1.61
  • MACD
  • TEVA -0.08
  • CNC 0.07
  • Stochastic Oscillator
  • TEVA 55.03
  • CNC 77.62

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About CNC Centene Corporation

Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.

Share on Social Networks: